All Stories

  1. Achalasia and esophageal cancer: risks and links
  2. Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometry
  3. Celiac disease and gastric hyperplastic polyps
  4. Microbiota gastrointestinal y síndrome de intestino irritable. Respuesta a García-Mazcorro
  5. Eosinophilic esophagitis prevalence in an adult population undergoing upper endoscopy in southeastern Mexico
  6. Sa1070 Epidemiology of Gastroesophageal Reflux (GERD) Symptoms in Mexico. A Nationwide Population Based Study
  7. Mo1980 MELD-Na Versus Discriminant Function Index (DFI) At Admission for Mortality Prediction in Mexican Patients With Alcoholic Hepatitis
  8. Su2059 Prevalence of Irritable Bowel Syndrome in Mexico. A Nationwide Population Based Study Using the ROME III Questionnaire
  9. Su1434 Celiac Disease Screening in Patients Previously Diagnosed With Infertility. A Prospective Study in Mexican Population
  10. 881 Effects of Telmisartan in Anal Sphincter Physiology in Asymptomatic Volunteers and Patients With Anal Sphincter Hypertension With Chronic Proctalgia
  11. Translumbar and Transsacral Magnetic Neurostimulation for the Assessment of Neuropathy in Fecal Incontinence
  12. Mo1888 Contraction Amplitude Is a Relevant Predictor of Bolus Transit During Sitting Viscous Solution Swallows in Healthy Individuals: Preliminary Results of a Multicenter Study Using High Resolution Impedance Manometry (HRIM)
  13. Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias
  14. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review
  15. Dental erosion, an extraesophageal manifestation of gastroesophageal reflux disease: the experience of a center for digestive physiology in Southeastern Mexico
  16. Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group
  17. Experiencia clínica con el uso de 2 sistemas de cápsula endoscópica en el diagnóstico de enfermedades del intestino delgado
  18. Expression of the Matrix Metalloproteases 2, 14, 24, and 25 and Tissue Inhibitor 3 as Potential Molecular Markers in Advanced Human Gastric Cancer
  19. Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational Study
  20. Application of colon capsule endoscopy (CCE) to evaluate the whole gastrointestinal tract: a comparative study of single-camera and dual-camera analysis
  21. “Too Hot” Or “Too Cold”: Effects of Meal Temperature on Gastric Function
  22. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection: A rare complication
  23. Response to Remes-Troche et al.
  24. Celiac Disease in Mexican Population: An Update
  25. A 'black stomach' due to ingestion of anhydrous calcium chloride
  26. Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers
  27. Colelitiasis y colecistectomía en pacientes con insuficiencia renal crónica
  28. Polar vectors as a method for evaluating the effectiveness of irritable bowel syndrome treatments: An analysis with pinaverium bromide 100mg plus simethicone 300mg po bid
  29. Glomus tumour of the stomach: an unusual cause of gastrointestinal bleeding
  30. Rectal tonsil associated with Epstein-Barr virus
  31. Esophageal motor disorders in subjects with incidentally discovered Chagas disease: a study using high-resolution manometry and the Chicago classification
  32. Consenso mexicano de enfermedad por relujo gastroesofágico. Parte I
  33. Perianal fibroadenoma
  34. Estreñimiento y trastornos anorrectales
  35. «El inglés: la quinta era del lenguaje de la medicina»
  36. Proton pump inhibitors in gastroesophageal reflux disease: a custom-tailored therapeutic regimen
  37. Diarrea asociada con infección por Clostridium difficile, ¿es tiempo de preocuparnos en México?
  38. Barostat or dynamic balloon distention test: which technique is best suited for esophageal sensory testing?
  39. Enterolithiasis associated with sigmoid stenosis caused by foreign body introduction
  40. Síntomas abdominales y gastrointestinales del dengue. Análisis de una cohorte de 8.559 pacientes
  41. Glándulas sebáceas ectópicas en esófago. Reporte de tres casos
  42. Investigation of anal motor characteristics of the sensorimotor response (SMR) using 3-D anorectal pressure topography
  43. A bi-directional assessment of the human brain-anorectal axis
  44. Bacterial Meningitis in Cirrhotic Patients
  45. The Hypersensitive Esophagus: Pathophysiology, Evaluation, and Treatment Options
  46. Rectoanal Reflexes and Sensorimotor Response in Rectal Hyposensitivity
  47. T1357 Investigation of Anal Motor Characteristics of the Sensori-Motor Response (SMR)
  48. M1119 Sequential Therapy vs. Standard Triple Therapy as Treatment of Helicobacter pylori Infection. A Prospective, Randomized, Parallel-Group, Open-Label Study in Mexico
  49. M1649 Management and Outcomes of Patients With Acute Pancreatitis. Differences According to Admitting Service
  50. M1337 Irritable Bowel Syndrome (IBS) Among Caregivers of Chronically Ill Patients: Prevalence, Quality of Life (QOL) and Association With Psychological Stress
  51. S1332 Expected Frequency of Stool Patterns According to the Bristol Scale After 4 Weeks of Treatment With Pinaverium Bromide + Simethicone for IBS ROME III Patients. A Report From the Mexican IBS Working Group
  52. 583 The Role of Adenosine in Esophageal Nociception in Patients with Functional Chest Pain
  53. T1225 The Effects of Caffeine On Sensed Acid Reflux Events and Esophageal Acid Exposure Among Different Groups of GERD Patients
  54. W1862 Esophageal Motor Disorders in Subjects with Chronic Indeterminate Chagas Disease: A Study Using High Resolution Manometry.
  55. S2086 Relation of Bloating with Food Intake and Other Symptoms in IBS. A Report of the Mexican IBS Working Group
  56. W2038 Novel Test of Bi-Directional Assessment of Brain-Anorectal Axis in Healthy Humans
  57. T1264 The Effect of 4 Weeks of Treatment with Pinaverium Bromide (PB) + Symethicone (S) On Symptom Intensity in IBS-ROME III Patients. a Report of the Mexican IBS Working Group
  58. Early gastric cancer in Menetrier's disease
  59. Routine Liver Biopsy to Screen for Nonalcoholic Fatty Liver Disease (NAFLD) during Cholecystectomy for Gallstone Disease: Is it Justified?
  60. Neurophysiological testing in anorectal disorders
  61. High Prevalence of Celiac Disease in Mexican Mestizo Adults With Type 1 Diabetes Mellitus
  62. S1826 Translumbar and Transsacral Magnetic Stimulation–a Novel Test of Assessing Anorectal Neuropathy in Fecal Incontinence
  63. S1810 Evaluation of Spino-Anorectal Pathways in Spinal Cord Injury with Bowel Dysfunction Using Magnetic Stimulation: A Novel and Noninvasive Test
  64. M1784 Is Sexual and Physical Abuse in Irritable Bowel Syndrome (IBS) Related to An Impaired Health-Related Quality of Life?
  65. S1836 Functional Anorectal Disorders Are More Prevalent in Women with a History of Sexual Abuse
  66. 681 Routine Liver Biopsy to Detect Non-Alcoholic Fatty Liver Disease (NAFLD) During Laparoscopic Cholecystectomy for Symptomatic Gallstone Disease (GD). Is It Justified?
  67. Adenosine modulates oesophageal sensorimotor function in humans
  68. Efficacy and safety of neutral pH superoxidised solution in severe diabetic foot infections
  69. Cholestyramine—a useful adjunct for the treatment of patients with fecal incontinence
  70. Rectoanal Sensorimotor Response in Humans During Rectal Distension
  71. Anorectal motor disorders
  72. Intraepithelial γδ+ Lymphocytes
  73. Theophylline Improves Esophageal Chest Pain?A Randomized, Placebo-Controlled Study
  74. Drinking Capacity and Severity of Dyspeptic Symptoms During a Water Load Test After Nissen Fundoplication
  75. Functional Chest Pain
  76. Altered esophageal sensory–motor function in patients with persistent symptoms after Nissen fundoplication
  77. When Should We Be Concerned about Pancreatic Necrosis? Analysis from a Single Institution in Mexico City
  78. Diagnostic testing in patients with chronic constipation
  79. Celiac Disease Could be a Frequent Disease in Mexico: Prevalence of Tissue Transglutaminase Antibody in Healthy Blood Donors
  80. Defecation disorders: Neuromuscular aspects and treatment
  81. Response to Letter by Hendrikus Vanderveldt
  82. Image of the month
  83. Performance, Tolerability, and Symptoms Related to Prolonged pH Monitoring Using the Bravo System in Mexico
  84. Progressive Dysphagia Caused by Isolated Esophageal Involvement of Crohnʼs Disease
  85. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome
  86. High prevalence of chlamydia pneumoniae seropositivity in mexican patients with ischemic heart disease
  87. Single pancreatic metastasis from a previously resected carcinoma of the cecum: a case report
  88. Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients
  89. IBS patients differ according to age: self-reported symptom severity is related
  90. Prognostic Factors of Thymectomy in Patients with Myasthenia Gravis
  91. IBS PATIENTS DIFFER ACCORDING TO AGE: SELF-REPORTED SYMPTOM SEVERITY IS RELATED
  92. Effect of Ulcerative Colitis in the Bursting Strength of Colonic Anastomoses in Rats
  93. Thalamic and Mesencephalic Hemorrhages after Multiple Honeybee Stings: A Life-Threatening Apitherapy Complication
  94. Thymectomy in Myasthenia Gravis
  95. Hepatoblastoma in adult age; a case report and review of the literature
  96. Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases
  97. Prognostic Factors of Thymectomy in Patients with Myasthenia gravis: A Cohort of 132 Patients